These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 33268335)

  • 21. A UK nationwide study of adults admitted to hospital with diabetic ketoacidosis or hyperosmolar hyperglycaemic state and COVID-19.
    Field BCT; Ruan Y; Várnai KA; Davies J; Ryder REJ; Gandhi R; Harris S; Nagi D; Patel D; Kempegowda P; Wild SH; Wilmot EG; Khunti K; Rea R; Narendran P;
    Diabetes Obes Metab; 2023 Jul; 25(7):2012-2022. PubMed ID: 37016487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of new-onset diabetic ketoacidosis in patients with moderate to severe COVID-19 receiving parenteral glucocorticoids: A prospective single-centre study among Indian type 2 diabetes patients.
    Mondal S; DasGupta R; Lodh M; Gorai R; Choudhury B; Hazra AK; Ganguly A
    Diabetes Metab Syndr; 2021; 15(3):795-801. PubMed ID: 33839639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Association of Obesity, Type 2 Diabetes, and Hypertension with Severe Coronavirus Disease 2019 on Admission Among Mexican Patients.
    Denova-Gutiérrez E; Lopez-Gatell H; Alomia-Zegarra JL; López-Ridaura R; Zaragoza-Jimenez CA; Dyer-Leal DD; Cortés-Alcala R; Villa-Reyes T; Gutiérrez-Vargas R; Rodríguez-González K; Escondrillas-Maya C; Barrientos-Gutiérrez T; Rivera JA; Barquera S
    Obesity (Silver Spring); 2020 Oct; 28(10):1826-1832. PubMed ID: 32610364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comorbidities increase COVID-19 hospitalization in young people with type 1 diabetes.
    Mann EA; Rompicherla S; Gallagher MP; Alonso GT; Fogel NR; Simmons J; Wood JR; Wong JC; Noor N; Gomez P; Daniels M; Ebekozien O
    Pediatr Diabetes; 2022 Nov; 23(7):968-975. PubMed ID: 36054578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study.
    Íñiguez M; Pérez-Matute P; Villoslada-Blanco P; Recio-Fernandez E; Ezquerro-Pérez D; Alba J; Ferreira-Laso ML; Oteo JA
    Front Endocrinol (Lausanne); 2021; 12():688071. PubMed ID: 34489863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients.
    Shin EK; Choi HY; Hayes N
    Epidemiol Health; 2021; 43():e2021035. PubMed ID: 33971700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HbA
    Zhong VW; Juhaeri J; Cole SR; Shay CM; Gordon-Larsen P; Kontopantelis E; Mayer-Davis EJ
    J Diabetes Complications; 2018 Feb; 32(2):203-209. PubMed ID: 29242016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantifying association and disparities between diabetes complications and COVID-19 outcomes: A retrospective study using electronic health records.
    Paramita NLPSP; Agor JK; Mayorga ME; Ivy JS; Miller KE; Ozaltin OY
    PLoS One; 2023; 18(9):e0286815. PubMed ID: 37768993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Mortality Rate and Severity of Pulmonary Involvement in Coronavirus Disease-2019 Adult Patients With and Without Type 2 Diabetes: A Cohort Study.
    Khalili S; Moradi O; Kharazmi AB; Raoufi M; Sistanizad M; Shariat M
    Can J Diabetes; 2021 Aug; 45(6):524-530. PubMed ID: 33339741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient Characteristics Associated With Severe Hypoglycemia in a Type 2 Diabetes Cohort in a Large, Integrated Health Care System From 2006 to 2015.
    Misra-Hebert AD; Pantalone KM; Ji X; Milinovich A; Dey T; Chagin KM; Bauman JM; Kattan MW; Zimmerman RS
    Diabetes Care; 2018 Jun; 41(6):1164-1171. PubMed ID: 29549082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age and Hospitalization Risk in People With Type 1 Diabetes and COVID-19: Data From the T1D Exchange Surveillance Study.
    Demeterco-Berggren C; Ebekozien O; Rompicherla S; Jacobsen L; Accacha S; Gallagher MP; Todd Alonso G; Seyoum B; Vendrame F; Haw JS; Basina M; Levy CJ; Maahs DM
    J Clin Endocrinol Metab; 2022 Jan; 107(2):410-418. PubMed ID: 34581790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Diabetes Severity and Risks of COVID-19 Infection and Outcomes.
    Floyd JS; Walker RL; Kuntz JL; Shortreed SM; Fortmann SP; Bayliss EA; Harrington LB; Fuller S; Albertson-Junkans LH; Powers JD; Lee MH; Temposky LA; Dublin S
    J Gen Intern Med; 2023 May; 38(6):1484-1492. PubMed ID: 36795328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Independent Impact of Diabetes on the Severity of Coronavirus Disease 2019 in 5,307 Patients in South Korea: A Nationwide Cohort Study.
    Moon SJ; Rhee EJ; Jung JH; Han KD; Kim SR; Lee WY; Yoon KH
    Diabetes Metab J; 2020 Oct; 44(5):737-746. PubMed ID: 33115212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic ketoacidosis drives COVID-19 related hospitalizations in children with type 1 diabetes.
    Alonso GT; Ebekozien O; Gallagher MP; Rompicherla S; Lyons SK; Choudhary A; Majidi S; Pinnaro CT; Balachandar S; Gangat M; Curda Roberts AJ; Marks BE; Creo A; Sanchez J; Seeherunvong T; Jimenez-Vega J; Patel NS; Wood JR; Gabriel L; Sumpter KM; Wilkes M; Rapaport R; Cymbaluk A; Wong JC; Sanda S; Albanese-O'neill A
    J Diabetes; 2021 Aug; 13(8):681-687. PubMed ID: 33855813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID-19 patients: Comparison with influenza and pre-pandemic data.
    Dell'Aquila K; Lee J; Wang SH; Alamuri TT; Jennings R; Tang H; Mahesh S; Leong TJ; Fleysher R; Henninger EM; Veeraraghavan S; Mirhaji P; Hou W; Herold KC; Duong TQ
    Diabetes Obes Metab; 2023 Sep; 25(9):2482-2494. PubMed ID: 37254311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Prevalence of Diabetes Among Hospitalized COVID-19 Minority Patients: Data from a Single Tertiary Hospital.
    Ashktorab H; Oskrochi G; Challa SR; Chirumamilla LG; Ahangarzadeh F; Jones-Wonni B; Shayegh N; Rashid M; Naqvi Z; Ekpe E; Sabyasachi S; Zenebe A; Brim H
    J Racial Ethn Health Disparities; 2024 Aug; 11(4):2488-2497. PubMed ID: 37500830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk analysis of COVID-19 hospitalization and critical care by race and region in the United States: a cohort study.
    Jimbo M; Saito S; Uematsu T; Hanaki H; Otori K; Shibuya K; Ando W
    BMC Public Health; 2023 Aug; 23(1):1489. PubMed ID: 37542210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study.
    Hopkins R; Young KG; Thomas NJ; Godwin J; Raja D; Mateen BA; Challen RJ; Vollmer SJ; Shields BM; McGovern AP; Dennis JM
    BMJ Open; 2024 Jan; 14(1):e078135. PubMed ID: 38296292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cohort profile: National Diabetes Audit for England and Wales.
    Holman N; Knighton P; Wild SH; Sattar N; Dew C; Gregg EW; Khunti K; Valabhji J; Young B
    Diabet Med; 2021 Sep; 38(9):e14616. PubMed ID: 34062007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.